The MAL2 protein has now been known to interact with the MHC-I complex and endosome-associated RAB proteins to inhibit the presentation of MHC-I molecules on cell membrane to drive immune evasion in breast cancer [2]. This evidence concerns the gene MAL2 and breast carcinoma.